Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.11, 2010-11, pp. : 1023-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery and Development of the Epothilones: A Novel Class of Antineoplastic Drugs

By Reichenbach Hans Höfle Gerhard

Drugs in R&D, Vol. 9, Iss. 1, 2008-01 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite

Optimization of Small Molecule Drugs Binding to Highly Polar Target Sites: Lessons from the Discovery and Development of Neuraminidase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-03 ,pp. : 423-434

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Binding Kinetics in GPCR Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 24, 2015-01 ,pp. : 2504-2522

Bentham Science Publishers

Access to resources Recommend Favorite

The role of dopamine in the mechanism of action of antidepressant drugs

By D'Aquila P.S. Collu M. Gessa G.L. Serra G.

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 365-373

Elsevier

Access to resources Recommend Favorite

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

By Horacek Jiri Bubenikova-Valesova Vera Kopecek Milan Palenicek Tomas Dockery Colleen Mohr Pavel Höschl Cyril

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 389-409

Adis International

Access to resources Recommend Favorite